 Iqvia Holdings Inc NYSE: IQV has collaborated with NRx Pharmaceuticals Inc NASDAQ: NRXP to provide pharmacovigilance services and medical information in preparation for potential regulatory actions. IQVIA will work closely with NRx to support key activities required for emergency use authorization activation for Zyesami in COVID-19, including the pharmacovigilance and medical information programs. 